The U.S. M&A landscape remains active, with proxy filings, shareholder votes, financing arrangements and closing preparations driving the latest deal developments across healthcare, technology, financial services, energy and industrials. 🔹 Key Deal Developments $ON / $SYNA: ON Semiconductor’s CFO resigned, with the CEO set to serve as principal financial officer while the proposed Synaptics transaction remains pending. $ZYME / $TBPH: Zymeworks filed its definitive proxy statement, with shareholders scheduled to vote on the proposed Theravance Biopharma transaction on September 18. $MRK / $TECH: Merck KGaA filed its definitive proxy statement for the proposed acquisition of Bio-Techne, with the shareholder vote scheduled for September 23. $REAX / $RMAX: Real Brokerage and RE/MAX Holdings announced preliminary results for shareholders’ elections of merger consideration, marking another step toward completing the transaction. $ICE / $MKTX: Intercontinental Exchange completed a $3.71 billion senior-notes offering to help finance its planned acquisition of MarketAxess. $CRBG / $EQH: Corebridge Financial announced a $750 million 5.900% senior-notes offering due 2036 as preparations continue for its transaction with Equitable Holdings. $MDXG / $SMTI: MiMedx announced a distributor communication related to its planned acquisition, with closing expected by year-end. $NEE / $D: NextEra Energy continues promoting the potential benefits of its proposed Dominion Energy transaction for Virginia. $TEM / $PSNL: Tempus AI received a new $18.3 million Department of Veterans Affairs task order, providing an additional business-development catalyst. Altaris / $SLP: A supplemental definitive proxy was filed with updated litigation disclosures related to the pending transaction. 🎯 M&A Watch The latest developments highlight the next important stages of several transactions: shareholder approvals, proxy updates, financing, regulatory processes and closing milestones. Investors should continue watching these events closely as they can influence deal certainty, timelines and potential arbitrage opportunities.